NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of AmerisourceBergen Corporation (ABC).
On October 1, 2018, the U.S. Department of Justice announced that the company will pay $625 million to resolve civil fraud charges over related conduct, bringing AmerisourceBergen’s total payments to $885 million over its repackaging and distribution of pre-filled syringes that were not approved by the U.S. Food and Drug Administration.
If you are a long term stockholder of AmerisourceBergen, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into AmerisourceBergen please go to https://bespc.com/abc/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.